Histamine H1 receptor ligands. Part I. Novel thiazol-4-ylethanamine derivatives: Synthesis and in vitro pharmacology

Farmaco

Volumn 54, Issue 8, 1999, Pages 533-541

  Walczynski K ^a   Timmerman, H ^b   Zuiderveld, O P ^b   Zhang, M Q ^b   Glinka, R ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

2 (2 Benzylthiazol 4 yl)ethanamines; 2 (2 Phenylthiazol 4 yl)ethanamines; H1 receptor agonist; H1 receptor antagonists; Histamine H1 receptor

Indexed keywords

ATROPINE; HISTAMINE DERIVATIVE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR AGONIST; TEMELASTINE; THIAZOLIDINE DERIVATIVE; HISTAMINE AGONIST; LIGAND; THIAZOLE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GUINEA PIG; ILEUM; IN VITRO STUDY; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; ANIMAL; DOSE RESPONSE; DRUG EFFECT; MALE; MUSCLE CONTRACTION; SMOOTH MUSCLE; SYNTHESIS;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HISTAMINE AGONISTS; ILEUM; LIGANDS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

EID: 0032589350     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00060-9     Document Type: Article

References (28)

1. M.Q. Zhang, R. Leurs, H. Timmerman, in: M.E. Wolff (Ed.), Medicinal Chemistry and Drug Discovery, fifth ed., vol. 5: Therapeutic agents, Wiley, New York, 1997, p. 495.
2. Zingel V., Leschke C., Schunack W. Jucker E Progress in Drug Research. 44:1995;49 Birkhäuser, Basel, Switzerland.
3. Barlow R.B. Introduction to Chemical Pharmacology. second ed. 1964;344 Methuen, London.
4. Jones R.G. Rocha e Silva M Handbook Exp. Pharmacol. XVIII/I Histamine and Antihistaminics. 1966;1 Springer, Berlin.
5. Paton D.M. Schachter M Histamines and Antihistamines. 1:1973;3 Pergamon, Oxford.
6. Ganellin C.R. Ganellin C.R., Parsons M.E. Pharmacology of Histamine Receptor. 1982;10 Wright-PSC, Bristol, London, Boston.
7. Cooper D.G., Durant G.J., Ganellin C.R. Emmett J.C. Comprehensive Medicinal Chemistry. 3:1990;323 Pergamon, Oxford.
8. Leurs R., van der Goot H., Timmerman H. Adv. Drug Res. 20:1991;218.
9. Dziuron P., Schunack W. Eur. J. Med. Chem. 10:1975;129.
10. Hepp M., Dziuron P., Schunack W. Arch. Pharm. (Weinheim). 312:1979;637.
11. Koper J.G., van der Vliet A., van der Goot H., Timmerman H. Pharm. Weekbl. Sci. Ed. 12:1990;236.
12. Leschke C., Elz S., Garbarg M., Schunack W. J. Med. Chem. 38:1995;1287.
13. Zingel V., Elz S., Schunack W. Eur. J. Med. Chem. 25:1990;673.
14. Durant J., Ganellin C.R., Parsons M.E. J. Med. Chem. 18:1975;905.
15. Jones R.G., Kornfeld E.C., McLaughlin K.C. J. Am. Chem. Soc. 72:1950;4526.
16. Lee H.M., Jones R.G. J. Pharmacol. Exp. Ther. 95:1949;71.
17. Schunack W. Arch. Pharm. (Weinheim). 308:1975;75.
18. A.E.S. Fairfull, J.L. Lowe, D.A. Peak, J. Chem. Soc. 742 (1952).
19. Scheibye S., Pedersen B.S., Lawesson S.O. Bull. Soc. Chim. Belg. 87:1978;229.
20. K.E. Brighty, J.A. Lowe, P.R. McGuirk, US Patent 5037834 (1991).
21. Brown E.A., Griffiths R., Harvey C.A., Owen D.A.A. Br. J. Pharmacol. 87:1986;569.
22. Detert H., Leschke C., Tögel W., Seifert R., Schunack W. Eur. J. Med. Chem. 31:1996;397.
23. Ter Laak A.M., Timmerman H., Leurs R., Nederkoorn P.H.J., Smit M.J., Donne-Op den Kelder G.M. J. Comp-Aided. Mol. Des. 9:1995;319.
24. Van Rossum J.M. Arch. Int. Pharmacodyn. Ther. 143:1963;299.
25. Arunlakshana O., Schild H.O. Br. J. Pharmacol. 14:1959;48.
26. Hinegardner W.S., Johnson T.B. J. Am. Chem. Soc. 52:1930;3724.
27. Palazzo G., Tavella M. Gazz. Chim. Ital. 92:1962;1084.
28. Burger A., Ullyot G.E. J. Org. Chem. 12:1947;342.